Axial Biotech (Salt Lake City, UT) developer of spine surgical devices and molecular prognostic diagnostic for adolescent scoliosis, closed a $6M Series B financing. Participants include Johnson & Johnson Development Corp., vSpring Capital and Ohio Biotech Group.